Hemorrhagic synovitis
Conditions
Interventions
Sponsors
Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) The patients with hemorrhagic synovitis undergoing arthroscopic debridement; (2) Normal platelet and coagulation function preoperatively; (3) Normal intravenous ultrasound in the lower extremities preoperatively; (4) To be able to and willing to provide signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Systemic infections such as pulmonary infection or urinary tract infection are not controlled preoperatively; (2) Abnormal immune function or combined immune-related disease preoperatively; (3) Abnormal inflammatory index preoperatively (C-reactive protein >20 mg/L); (4) Abnormal fibrinolysis index preoperatively (FDP > 5mg/L); (5) Discontinuation of oral anticoagulants or aspirin less than 1 week; (6) Allergy to tranexamic acid (TXA) or dexamethasone or have contraindications; (7) Patients at high risk of thrombosis; (8) History of deep vein thrombosis (VTE, calf muscle vein thrombosis or superficial vein thrombosis, pulmonary embolism); (9) serious liver and kidney dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood loss; | — |
Secondary
| Measure | Time frame |
|---|---|
| ESR, CRP, IL-6,IL-10;Hb;Hct;DVT, PE;Transfusion;Swelling;VAS pain score;color Doppler Ultrasonic (CDU) examination in lower extremity;ROM;IKDC;Lysholm;Muscle strength;Coagulation index;Drainage;Satisfaction scores;Analysis of joint fluid composition;protein chemistry and enzyme mechanism/Metabolism;TXA metabolism and outcome; | — |
Countries
China
Contacts
Public ContactJian Li
West China Hospital, Sichuan University
Outcome results
None listed